Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PF-08046048 by Pfizer for Epithelial Ovarian Cancer: Likelihood of Approval
PF-08046048 is under clinical development by Pfizer and currently in Phase I for Epithelial Ovarian Cancer. According to GlobalData, Phase...
PF-08046048 by Pfizer for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
PF-08046048 is under clinical development by Pfizer and currently in Phase I for Human Epidermal Growth Factor Receptor 2 Negative...
PF-08046048 by Pfizer for Fallopian Tube Cancer: Likelihood of Approval
PF-08046048 is under clinical development by Pfizer and currently in Phase I for Fallopian Tube Cancer. According to GlobalData, Phase...
PF-08046048 by Pfizer for Peritoneal Cancer: Likelihood of Approval
PF-08046048 is under clinical development by Pfizer and currently in Phase I for Peritoneal Cancer. According to GlobalData, Phase I...